Skip to Main Content
Newsroom
BD & Partnering
Get in Touch
LinkedIn
X Mobile
Editas Medicine Linkedin
Research and Pipeline
CRISPR Gene Editing
For Patients
Who We Are
Join Our Team
Investors
Newsroom
BD & Partnering
Get in Touch
LinkedIn
X Mobile
ASGCT 2024 LSR Poster
May 9, 2024
By
+
-
Editas Newsroom
May
28
Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference
May
26
Editas Medicine Announces Pricing of Up to $319.4 Million Public Offering
May
26
Editas Medicine Announces Proposed Public Offering